<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:department>College of Medical, Veterinary &amp;Life Sci</gtr:department><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/AE58F21F-3622-4382-97BB-1359BD183E9F"><gtr:id>AE58F21F-3622-4382-97BB-1359BD183E9F</gtr:id><gtr:name>University of Glasgow</gtr:name><gtr:address><gtr:line1>University Avenue</gtr:line1><gtr:line4>Glasgow</gtr:line4><gtr:postCode>G12 8QQ</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5FC4C032-4778-4A82-95CD-13F5897F599B"><gtr:id>5FC4C032-4778-4A82-95CD-13F5897F599B</gtr:id><gtr:name>Joint Bioenergy Institute</gtr:name><gtr:address><gtr:line1>5885 Hollis Street</gtr:line1><gtr:postCode>CA 94608</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0BF12FB6-EEAD-4536-BC76-BA5D67259245"><gtr:id>0BF12FB6-EEAD-4536-BC76-BA5D67259245</gtr:id><gtr:firstName>Susan</gtr:firstName><gtr:otherNames>Jane</gtr:otherNames><gtr:surname>Rosser</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FL004321%2F1"><gtr:id>8D40C40D-E515-4D94-9AF0-3A7A71F27EA1</gtr:id><gtr:title>Research visit to the Joint BioEnergy Institute CA</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/L004321/1</gtr:grantReference><gtr:abstractText>United States</gtr:abstractText><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>5000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The overarching aim was to develop new Synthetic Biology chassis strains for advanced metabolic engineering for production of biofuels and high value small molecules. In order to accomplish this as part of the proposed visit we demonstrated recombinase based gene deletion for metabolic pathway flux optimization.</gtr:description><gtr:exploitationPathways>These preliminary findings have been used to develop projects with industrial collaborators such as Ingenza and Unilever</gtr:exploitationPathways><gtr:id>034773F8-F898-4440-B61B-FB98B8550079</gtr:id><gtr:outcomeId>5463edaba039d2.67420371</gtr:outcomeId><gtr:sectors><gtr:sector>Chemicals,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developed (and are continuing to develop) new methods for rapid efficient assembly of DNA fragments using serine integrases.</gtr:description><gtr:id>5BD21582-1BD4-4F56-891E-A2FEF3D56F91</gtr:id><gtr:impact>First version of the method is published (S.D. Colloms et al., Nucleic Acids Res. 42, e23).</gtr:impact><gtr:outcomeId>56caf9a00768f9.74514783</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Novel methods for gene assembly</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>BA475F4C-E5A7-47FE-BEFB-97F6B0FC11F5</gtr:id><gtr:title>Rapid metabolic pathway assembly and modification using serine integrase site-specific recombination.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e1469853cf9b03c4f19c8abbb7edea3b"><gtr:id>e1469853cf9b03c4f19c8abbb7edea3b</gtr:id><gtr:otherNames>Colloms SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>5463dccde07ec8.83541456</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/L004321/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>